MS patients benefit from numerus disease modifying therapies. Fatigue; pain; and disability can form part of an MS patients life; the position of exercise and activities will be explored in this presentation. The benefits of activity & exercise to the patient will be explored in view and context of published work. A comparison will be made of published vs. pragmatic and anecdotal experience with exercise & activity through the lens of a physiotherapist. From an academic standpoint: the impact of exercise & activity on neuroplasticity (central & peripheral); neurotransmitters and clinical trial work will also be explored.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare.
